Stuart Holden insider trades

Open-market stock purchases and sales by Stuart Holden, Director at UroGen Pharma Ltd, from SEC Form 4 filings since Jun 3, 2019.

Recent trades

DateStockTradeValue
Jun 22, 2026URGN UroGen Pharma LtdBought (not open market)—
Nov 26, 2025URGN UroGen Pharma LtdBought (not open market)—

Companies traded

  • URGN UroGen Pharma Ltd: other filings, last Jun 22, 2026

Get free alerts when Stuart Holden files a new trade →